Short description
ImmusanT is a biotechnology company developing diagnostics and therapeutics for the diagnosis and treatment of celiac disease.
Description
ImmusanT is a biotechnology company that develops diagnostics and therapeutics for the diagnosis and treatment of celiac disease. The company focuses on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that improve diagnosis and treatment. It develops Nexvax2, a therapeutic vaccine for treating, preventing, and diagnosing celiac disease. The company also develops a functional T-cell test to diagnose and monitor the maintenance of immune tolerance with peptide based therapy.
ImmusanT was incorporated in 2010 and is based in Cambridge, Massachusetts.
Total funding
$$2020202
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
June 8, 2011
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Absolutely Noaccess, Cannot Access
Sign in for full access
Founders
Leslie Williams